Operating Income (Loss) in USD of RESMED INC from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Resmed Inc quarterly/annual Operating Income (Loss) history and change rate from Q1 2010 to Q3 2025.
  • Resmed Inc Operating Income (Loss) for the quarter ending 30 Sep 2025 was $447M, a 15.3% increase year-over-year.
  • Resmed Inc Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $1.74B, a 23% increase year-over-year.
  • Resmed Inc annual Operating Income (Loss) for 2025 was $1.69B, a 27.7% increase from 2024.
  • Resmed Inc annual Operating Income (Loss) for 2024 was $1.32B, a 16.6% increase from 2023.
  • Resmed Inc annual Operating Income (Loss) for 2023 was $1.13B, a 13.2% increase from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

RESMED INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.74B $447M +$59.2M +15.3% 01 Jul 2025 30 Sep 2025 10-Q 31 Oct 2025
Q2 2025 $1.69B $455M +$73.3M +19.2% 01 Apr 2025 30 Jun 2025 10-K 08 Aug 2025
Q1 2025 $1.61B $426M +$51.7M +13.8% 01 Jan 2025 31 Mar 2025 10-Q 24 Apr 2025
Q4 2024 $1.56B $417M +$142M +51.7% 01 Oct 2024 31 Dec 2024 10-Q 31 Jan 2025
Q3 2024 $1.42B $387M +$98.3M +34% 01 Jul 2024 30 Sep 2024 10-Q 31 Oct 2025
Q2 2024 $1.32B $381M +$106M +38.5% 01 Apr 2024 30 Jun 2024 10-K 08 Aug 2025
Q1 2024 $1.21B $375M +$73.9M +24.6% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2025
Q4 2023 $1.14B $275M -$5.1M -1.82% 01 Oct 2023 31 Dec 2023 10-Q 31 Jan 2025
Q3 2023 $1.15B $289M +$13.3M +4.81% 01 Jul 2023 30 Sep 2023 10-Q 25 Oct 2024
Q2 2023 $1.13B $275M +$19.9M +7.78% 01 Apr 2023 30 Jun 2023 10-K 08 Aug 2025
Q1 2023 $1.11B $301M +$66.4M +28.3% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024
Q4 2022 $1.05B $280M +$31.5M +12.7% 01 Oct 2022 31 Dec 2022 10-Q 25 Jan 2024
Q3 2022 $1.01B $276M +$13.8M +5.28% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 $1B $255M +$13.8M +5.69% 01 Apr 2022 30 Jun 2022 10-K 09 Aug 2024
Q1 2022 $987M $234M +$10.8M +4.85% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023
Q4 2021 $976M $249M +$27M +12.2% 01 Oct 2021 31 Dec 2021 10-Q 27 Jan 2023
Q3 2021 $949M $262M +$45M +20.8% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022
Q2 2021 $904M $242M +$18.4M +8.24% 01 Apr 2021 30 Jun 2021 10-K 11 Aug 2023
Q1 2021 $885M $223M +$5.93M +2.73% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022
Q4 2020 $879M $222M +$23.9M +12.1% 01 Oct 2020 31 Dec 2020 10-Q 28 Jan 2022
Q3 2020 $855M $217M +$45.8M +26.8% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021
Q2 2020 $810M $223M +$102M +84.4% 01 Apr 2020 30 Jun 2020 10-K 12 Aug 2022
Q1 2020 $707M $218M +$60.5M +38.6% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021
Q4 2019 $647M $198M +$40.7M +25.9% 01 Oct 2019 31 Dec 2019 10-Q 29 Jan 2021
Q3 2019 $606M $171M +$27M +18.7% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020
Q2 2019 $579M $121M -$25.8M -17.6% 01 Apr 2019 30 Jun 2019 10-K 17 Aug 2021
Q1 2019 $605M $157M +$20.6M +15.1% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020
Q4 2018 $584M $157M +$11.1M +7.58% 01 Oct 2018 31 Dec 2018 10-Q 31 Jan 2020
Q3 2018 $573M $144M +$31.6M +28.1% 01 Jul 2018 30 Sep 2018 10-Q 25 Oct 2019
Q2 2018 $542M $147M +$19.5M +15.3% 01 Apr 2018 30 Jun 2018 10-K 13 Aug 2020
Q1 2018 $522M $136M +$29M +27% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q4 2017 $493M $146M +$49.1M +50.7% 01 Oct 2017 31 Dec 2017 10-Q 01 Feb 2019
Q3 2017 $444M $113M +$18.4M +19.6% 01 Jul 2017 30 Sep 2017 10-Q 26 Oct 2018
Q2 2017 $426M $127M +$8.72M +7.35% 01 Apr 2017 30 Jun 2017 10-K 08 Aug 2019
Q1 2017 $417M $107M +$3.09M +2.96% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018
Q4 2016 $414M $96.9M -$11.1M -10.3% 01 Oct 2016 31 Dec 2016 10-Q 24 Jan 2018
Q3 2016 $425M $94.1M -$3.88M -3.96% 01 Jul 2016 30 Sep 2016 10-Q 27 Oct 2017
Q2 2016 $429M $119M +$19.1M +19.2% 01 Apr 2016 30 Jun 2016 10-K 17 Aug 2018
Q1 2016 $410M $104M -$1.56M -1.47% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017
Q4 2015 $411M $108M -$1.17M -1.07% 01 Oct 2015 31 Dec 2015 10-Q 25 Jan 2017
Q3 2015 $413M $98M +$3.35M +3.54% 01 Jul 2015 30 Sep 2015 10-Q 28 Oct 2016
Q2 2015 $409M $99.5M +$1.06M +1.08% 01 Apr 2015 30 Jun 2015 10-K 04 Aug 2017
Q1 2015 $408M $106M +$1.17M +1.12% 01 Jan 2015 31 Mar 2015 10-Q 29 Apr 2016
Q4 2014 $407M $109M +$4.13M +3.93% 01 Oct 2014 31 Dec 2014 10-Q 28 Jan 2016
Q3 2014 $403M $94.7M -$2.21M -2.28% 01 Jul 2014 30 Sep 2014 10-Q 27 Oct 2015
Q2 2014 $405M $98.5M +$12.3M +14.3% 01 Apr 2014 30 Jun 2014 10-K 05 Aug 2016
Q1 2014 $393M $105M +$8.6M +8.95% 01 Jan 2014 31 Mar 2014 10-Q 29 Apr 2015
Q4 2013 $384M $105M +$13M +14.1% 01 Oct 2013 31 Dec 2013 10-Q 30 Jan 2015
Q3 2013 $371M $96.9M +$16.4M +20.4% 01 Jul 2013 30 Sep 2013 10-Q 31 Oct 2014
Q2 2013 $355M $86.2M -$3.57M -3.97% 01 Apr 2013 30 Jun 2013 10-K 07 Aug 2015
Q1 2013 $358M $96.1M +$19.6M +25.5% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014
Q4 2012 $339M $92.1M +$24.8M +36.9% 01 Oct 2012 31 Dec 2012 10-Q 29 Jan 2014
Q3 2012 $314M $80.5M +$19.6M +32.2% 01 Jul 2012 30 Sep 2012 10-Q 30 Oct 2013
Q2 2012 $294M $89.7M +$23M +34.5% 01 Apr 2012 30 Jun 2012 10-K 08 Aug 2014
Q1 2012 $271M $76.5M +$12.6M +19.7% 01 Jan 2012 31 Mar 2012 10-Q 01 May 2013
Q4 2011 $259M $67.3M -$2.62M -3.75% 01 Oct 2011 31 Dec 2011 10-Q 31 Jan 2013
Q3 2011 $261M $60.9M -$5.52M -8.31% 01 Jul 2011 30 Sep 2011 10-Q 31 Oct 2012
Q2 2011 $267M $66.7M 01 Apr 2011 30 Jun 2011 10-K 13 Aug 2013
Q1 2011 $64M +$2.78M +4.55% 01 Jan 2011 31 Mar 2011 10-Q 01 May 2012
Q4 2010 $69.9M 01 Oct 2010 31 Dec 2010 10-Q 02 Feb 2012
Q3 2010 $66.4M 01 Jul 2010 30 Sep 2010 10-Q 03 Nov 2011
Q1 2010 $61.2M 01 Jan 2010 31 Mar 2010 10-Q 03 May 2011

RESMED INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $1.69B +$365M +27.7% 01 Jul 2024 30 Jun 2025 10-K 08 Aug 2025
2024 $1.32B +$188M +16.6% 01 Jul 2023 30 Jun 2024 10-K 08 Aug 2025
2023 $1.13B +$132M +13.2% 01 Jul 2022 30 Jun 2023 10-K 08 Aug 2025
2022 $1B +$96.6M +10.7% 01 Jul 2021 30 Jun 2022 10-K 09 Aug 2024
2021 $904M +$94M +11.6% 01 Jul 2020 30 Jun 2021 10-K 11 Aug 2023
2020 $810M +$230M +39.8% 01 Jul 2019 30 Jun 2020 10-K 12 Aug 2022
2019 $579M +$37.4M +6.91% 01 Jul 2018 30 Jun 2019 10-K 17 Aug 2021
2018 $542M +$116M +27.3% 01 Jul 2017 30 Jun 2018 10-K 13 Aug 2020
2017 $426M -$3.15M -0.74% 01 Jul 2016 30 Jun 2017 10-K 08 Aug 2019
2016 $429M +$19.7M +4.82% 01 Jul 2015 30 Jun 2016 10-K 17 Aug 2018
2015 $409M +$4.15M +1.02% 01 Jul 2014 30 Jun 2015 10-K 04 Aug 2017
2014 $405M +$50.3M +14.2% 01 Jul 2013 30 Jun 2014 10-K 05 Aug 2016
2013 $355M +$60.4M +20.5% 01 Jul 2012 30 Jun 2013 10-K 07 Aug 2015
2012 $294M +$27.5M +10.3% 01 Jul 2011 30 Jun 2012 10-K 08 Aug 2014
2011 $267M +$26.5M +11% 01 Jul 2010 30 Jun 2011 10-K 13 Aug 2013
2010 $240M 01 Jul 2009 30 Jun 2010 10-K 14 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.